Ozanimod Reduces axonal Damage and CNS-restricted and peripheral blood inflammation in RRMS: Soluble Biomarkers Analysis from AppreZiate RWE Study (NCT05811416)
Por:
França, LCF, Ruiz, LB, Fernandez, CM, Candeliere, A, Quilez, RB, Calles, C, Tello, CR, Canelo, LB, Codina, OC, Martinez, JM, Bravo, GCA, Gonzáles, JMP, Jimenez, DEB, García-Estévez, DA, Gimenez, FGG, Meca-Lallana, JE, Vilanova, D, Perez, X and Guimerans, LMV
Publicada:
1 sep 2025
Resumen:
Filiaciones:
França, LCF:
Int Ramon & Cajal Invest Sanitaria, Hosp Univ Ramon & Cajal, Neurol Dept, Madrid, Spain
Ruiz, LB:
Hosp Arnau Vilanova, Lleida, Spain
Fernandez, CM:
Hosp Torrecardenas, Almeria, Spain
Candeliere, A:
Hosp Rafael Mendez, Lorca, Spain
Quilez, RB:
Hosp Univ Puerta de Hierro, Madrid, Spain
Calles, C:
Hosp Univ Son Espases, Palma De Mallorca, Spain
:
Hosp Badalona Germans Trias & Pujol, Badalona, Spain
Canelo, LB:
Hosp Univ Fdn Alcorcon, Dept Neurol, Alcorcon, Spain
Codina, OC:
Hosp Figueres, Figueres, Spain
Martinez, JM:
Hosp Univ Miguel Servet, Zaragoza, Spain
Bravo, GCA:
Unit Neuroimmunol & Multiple Sclerosis Girona, Girona, Spain
Gonzáles, JMP:
H Clin Univ Santiago de Compostela, Santiago De Compostela, Spain
Jimenez, DEB:
Hosp Univ Guadalajara, Guadalajara, Spain
García-Estévez, DA:
Univ Hosp Ourense, Orense, Spain
Gimenez, FGG:
Hosp Clin Univ Valencia, Valencia, Spain
Meca-Lallana, JE:
Hosp Virgen Arrixaca, Murcia, Spain
Vilanova, D:
Bristol Myers Squibb, Madrid, Spain
Perez, X:
Bristol Myers Squibb, Madrid, Spain
Guimerans, LMV:
Hosp Univ Ramon & Cajal, Madrid, Spain
|